<?xml version="1.0" encoding="UTF-8"?>
<p id="p0080">There are no licensed drugs that specifically target SARS-CoV-2 (or other) coronaviruses. The scale of the COVID-19 pandemic, with more than 3 million cases and 230,000 deaths in 185 countries in a 4-month period, has driven an urgent search for drugs with antiviral activity against SARS-CoV-2. The fastest path to finding an effective treatment may be to repurpose licensed drugs that are approved for use in humans for other indications.</p>
